Low molecular weight heparin, a new prophylaxis in preventing deep vein thrombosis after surgery
Francone, F.; Grassano, M.T.; Pietrobono, M.; Torchia, T.
Gazzetta Medica Italiana Archivio per le Scienze Mediche 152(12): 489-490
1993
ISSN/ISBN: 0393-3660 Accession: 032203821
PDF emailed within 1 workday: $29.90
Related References
Handoll, H.H.; Farrar, M.J.; McBirnie, J.; Tytherleigh-Strong, G.; Awal, K.A.; Milne, A.A.; Gillespie, W.J. 2000: Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures Cochrane Database of Systematic Reviews 2000(2): Cd000305De, A.; Roy, P.; Garg, V.K.; Pandey, N.K. 2010: Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 21(1): 57-61
Li, X.L.; Lu, W.J.; Yu, N.S. 2001: Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15(1): 39-41
Nurmohamed, M.T.; Verhaeghe, R.; Haas, S.; Iriarte, J.A.; Vogel, G.; van Rij, A.M.; Prentice, C.R.; ten Cate, J.W. 1995: A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery American Journal of Surgery 169(6): 567-571
Cirlincione, A.S.; Mendicino, R.; Catanzariti, A.R.; Grossman, J. 2001: Low-molecular-weight heparin for deep vein thrombosis prophylaxis in foot and ankle surgery: a review Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 40(2): 96-100
Close, V.; Purohit, M.; Tanos, M.; Hunter, S. 2006: Should patients post-cardiac surgery be given low molecular weight heparin for deep vein thrombosis prophylaxis? Interactive Cardiovascular and Thoracic Surgery 5(5): 624-629
Dechavanne, M.; Ville, D.; Berruyer, M.; Trepo, F.; Dalery, F.; Clermont, N.; Lerat, J.L.; Moyen, B.; Fischer, L.P.; Kher, A.; Barbier, P. 2009: Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery Pathophysiology of Haemostasis and Thrombosis 19(1): 5-12
Dechavanne, M.; Ville, D.; Berruyer, M.; Trepo, F.; Dalery, F.; Clermont, N.; Lerat, J.L.; Moyen, B.; Fischer, L.P.; Kher, A. 1989: Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery Haemostasis 19(1): 5-12
Ghosh, A. 1999: Evidence-based evaluation of preoperative vs postoperative use of low-molecular-weight heparin in preventing deep vein thrombosis in elective hip surgery Archives of Internal Medicine 159(14): 1622-1623
Michot, M.; Conen, D.; Holtz, D.; Erni, D.; Zumstein, M.Daniel.; Ruflin, G.Bernhard.; Renner, N. 2002: Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low--molecular weight heparin Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 18(3): 257-263
Bergqvist, D.; Burmark, U.S.; Flordal, P.A.; Frisell, J.; Hallböök, T.; Hedberg, M.; Horn, A.; Kelty, E.; Kvitting, P.; Lindhagen, A. 1995: Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xai units in 2070 patients British Journal of Surgery 82(4): 496-501
Grunebaum, L.; Fricker J P.; Wiesel M L.; Vergnes, Y.; Cazenave J P.; Barbier, P.; Kher, A. 1987: Efficacy and safety of a low molecular weight heparin lmwh kabi 2165 in prophylaxis of postoperative deep vein thrombosis dvt after oncological surgery Thrombosis and Haemostasis 58(1): 118
Danis, J. 1995: Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xai units in 2070 patients British Journal of Surgery 82(9): 1283-1284
Ho, Y.H.; Seowchoen, F.; Leong, A.; Eu, K.W.; Nyam, D.; Teoh, M.K.; Mcleod, R.S. 1999: Randomized, controlled trial of low molecular weight heparin vs. no Deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients Diseases of the Colon and Rectum 42(2): 196-203
Ho, Y.H.; Seow-Choen, F.; Leong, A.; Eu, K.W.; Nyam, D.; Teoh, M.K. 1999: Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients Diseases of the Colon and Rectum 42(2): 196-202; Discussion: 202-203
Heilmann, L.; Tempelhoff, G.-F. V.; Kirkpatrick, C.; Schneider, D. M.; Hommel, G.; Pollow, K. 1998: Comparison of Unfractionated Versus Low Molecular Weight Heparin for Deep Vein Thrombosis Prophylaxis During Breast and Pelvic Cancer Surgery: Efficacy, Safety, and Follow-up Clinical and Applied Thrombosis/Hemostasis 4(4): 268-273
Lastória, S.; Rollo, H.A.; Yoshida, W.B.; Giannini, M.; Moura, R.; Maffei, F.H.A. 2006: Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin Acta Cirurgica Brasileira 21(3): 184-186
Hirsh, J. 1994: Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis New England Journal of Medicine 330(12): 862-863
Lotke, P.A.; Ecker, M.L. 1994: Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis New England Journal of Medicine 330(12): 863
Yang, G.; Lu, H.; Gao, J.; Kou, B.; Yuan, Y.; Xu, B. 2000: Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty Zhonghua Wai Ke Za Zhi 38(1): 25-27